These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2965214)

  • 1. Psychopharmacological therapy of deviant sexual behavior.
    Murray JB
    J Gen Psychol; 1988 Jan; 115(1):101-10. PubMed ID: 2965214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical use of antiandrogens in psychiatry].
    Hoffet H
    Gynakologe; 1980 Mar; 13(1):33-43. PubMed ID: 6219928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of sex offenses with antiandrogens].
    Kockott G
    Psychiatr Prax; 1983 Sep; 10(5):158-64. PubMed ID: 6227026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hormonal treatment of sexual offenders.
    Bradford JM
    Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477
    [No Abstract]   [Full Text] [Related]  

  • 5. The paraphilias and Depo-Provera: some medical, ethical and legal considerations.
    Berlin FS
    Bull Am Acad Psychiatry Law; 1989; 17(3):233-9. PubMed ID: 2529006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of paraphilic and nonparaphilic sexual disorders.
    Guay DR
    Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilibidinal drugs and mental retardation: a review.
    Clarke DJ
    Med Sci Law; 1989 Apr; 29(2):136-46. PubMed ID: 2526280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of oxyprothepine decanoate, lithium and cyproterone acetate on deviant sexual behavior].
    Bártová D; Buresová A; Hajnová R; Svestka J; Tichý P
    Cesk Psychiatr; 1986 Dec; 82(6):355-60. PubMed ID: 2879643
    [No Abstract]   [Full Text] [Related]  

  • 11. Policing "perversions": Depo-Provera and John Money's new sexual order.
    Tsang DC
    J Homosex; 1995; 28(3-4):397-426. PubMed ID: 7560938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M; Ingargiola GB; de Voogt H; Viggiano G; Barasolo E; Lardennois B; De Pauw M; Sylvester R
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to comments on two articles dealing with the teratogenicity of cyproterone acetate (CA) and medroxyprogesterone acetate (MPA).
    Spielmann H
    Teratology; 1985 Oct; 32(2):319-20. PubMed ID: 2931853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M; Martínez-Piñeiro JA; de Voogt H; Lardennois B; Nasta A; Zolfanelli R; Barasolo E; De Pauw M; Suciu S; Sulvester R
    Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of Depo-Provera in the treatment of sex offenders. The legal issues.
    Demsky LS
    J Leg Med; 1984 Jun; 5(2):295-322. PubMed ID: 6235301
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal and ethical issues in the use of antiandrogens in treating sex offenders.
    Melella JT; Travin S; Cullen K
    Bull Am Acad Psychiatry Law; 1989; 17(3):223-32. PubMed ID: 2529005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medroxyprogesterone treatment for paraphiliacs.
    Kravitz HM; Haywood TW; Kelly J; Wahlstrom C; Liles S; Cavanaugh JL
    Bull Am Acad Psychiatry Law; 1995; 23(1):19-33. PubMed ID: 7599368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings.
    Berlin FS; Meinecke CF
    Am J Psychiatry; 1981 May; 138(5):601-7. PubMed ID: 6453535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on sex offenders. Recent trends.
    Bradford JM
    Psychiatr Clin North Am; 1983 Dec; 6(4):715-31. PubMed ID: 6229722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproterone acetate in the treatment of sexual deviations.
    Zbytovský J; Zapletálek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(4):491-5. PubMed ID: 6451922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.